BMC Health Services Research (Aug 2019)

Testing population-based performance measures identifies gaps in juvenile idiopathic arthritis (JIA) care

  • Claire E.H. Barber,
  • Lisa M. Lix,
  • Diane Lacaille,
  • Deborah A. Marshall,
  • Kristine Kroeker,
  • Susanne Benseler,
  • Marinka Twilt,
  • Heinrike Schmeling,
  • Cheryl Barnabe,
  • Glen S. Hazlewood,
  • Vivian Bykerk,
  • Joanne Homik,
  • J. Carter Thorne,
  • Jennifer Burt,
  • Dianne Mosher,
  • Steven Katz,
  • Natalie J. Shiff

DOI
https://doi.org/10.1186/s12913-019-4379-4
Journal volume & issue
Vol. 19, no. 1
pp. 1 – 7

Abstract

Read online

Abstract Background The study evaluates Performance Measures (PMs) for Juvenile Idiopathic Arthritis (JIA): The percentage of patients with new onset JIA with at least one visit to a pediatric rheumatologist in the first year of diagnosis (PM1); and the percentage of patients with JIA under rheumatology care seen in follow-up at least once per year (PM2). Methods Validated JIA case ascertainment algorithms were used to identify cases from provincial health administrative databases in Manitoba, Canada in patients 12 and > 14 months between consecutive visits were also calculated. Results One hundred ninety-four incident JIA cases were diagnosed between 01/04/2008 and 03/31/2015. The median age at diagnosis was 9.1 years and 71% were female. PM1: Across the years, 51–81% of JIA cases saw a pediatric rheumatologist within 1 year. PM2: Between 58 and 78% of patients were seen in yearly follow-up. Gaps > 12, and > 14, months were observed once during follow-up in 52, and 34%, of cases, and ≥ twice in 11, and 5%, respectively. Conclusions Suboptimal access to pediatric rheumatologist care was observed which could lead to diagnostic and treatment delays and lack of consistent follow-up, potentially negatively impacting patient outcomes.

Keywords